Presenters:
Timothy Shuey, DO, Resident Physician, Internal Medicine Residency 
Geisinger Medical Center
 
Moderator: 
Michaelyn Notz, DO, Staff, General Pediatrics Professional Services
Geisinger Medical Center
 
Objectives: 
  • explain the role of SGLT2i for treating all heart failure patients
  • explain the role of GLP-1RA for treating type 2 diabetes in patients with co-morbid atherosclerotic cardiovascular disease
  • review the overlapping indications for SGLT2i and GLP-1RA in treating cardiovascular disease in a multi-morbid patient population (e.g. which patients would benefit most from which agents based on comorbidities
 
 
Session date: 
11/16/2023 - 12:30pm to 1:30pm EST
Location: 
Virtual using Microsoft Teams
Danville, PA
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 AOA Category 1-A
  • 1.00 Participation Credit
Please login or register to take this course.